Primary human colon cancer cells and high-grade adenomas are sensitive to TRAIL and combinational chemotherapies (e.g., using chloroquine and shogaol with TRAIL) could inhibit the proliferation of colon cells more effectively [12–16]. This evidence concerns the gene TNFSF10 and malignant colon neoplasm.